GeneFerm Strengthens Anaerobic and Precision Fermentation Capabilities to Advance as a Global-Standa
Exhibitor: GENEFERM BIOTECHNOLOGY CO., LTD.
Date: 2025-07-07
Booth No.: N604
As biotechnology continues to accelerate globally, GeneFerm is advancing R&D and process innovation by focusing on two high-barrier core areas: anaerobic microbial fermentation and precision fermentation, reinforcing its technical leadership and global competitiveness.
Strict anaerobic strains are extremely sensitive to oxygen, temperature, and humidity—requiring fully controlled, oxygen-free environments throughout cultivation, fermentation, freeze-drying, and packaging. Only a few companies worldwide have the capabilities to achieve stable mass production in this field, and GeneFerm is one of them.
In parallel, GeneFerm is actively developing precision fermentation technologies, leveraging microbes as cell factories to produce high-value functional ingredients. This enables reliable, consistent sourcing and addresses critical issues in the industrial supply chain.
GeneFerm has established a scalable fermentation platform that meets international quality standards, offering integrated and flexible CDMO services. Moving forward, the company will continue to promote microbial innovation, drive cross-industry applications, and uphold its commitment to sustainability and eco-friendly manufacturing.
GeneFerm — not just fermentation, but expanding the future of microbial innovation.
More Exhibitor's Press Release
- 2025微脂體高值新藥開發 CDMO 產業說明會圓滿成功，業界專家共探創新契機 ZILLION FINE CHEMICAL INTERNATIONAL CO., LTD. / 2025-07-07
- 潤雅生技與日本精化簽署合作備忘錄(MOU) 攜手日隆精化，共拓CDMO業務版圖 ZILLION FINE CHEMICAL INTERNATIONAL CO., LTD. / 2025-07-07
- 日隆精化攜瑞采生技參訪日本精化 助推腎病高值新藥IND微脂體製備 ZILLION FINE CHEMICAL INTERNATIONAL CO., LTD. / 2025-07-07
- Latest Innovations! GeneFerm Collaborates with NTU to Launch: GFRena2, TestoPro, and AquaSoiivon GENEFERM BIOTECHNOLOGY CO., LTD. / 2025-07-07
- GeneFerm Biotechnology – Your Trusted CDMO Partner in Fermentation Technology GENEFERM BIOTECHNOLOGY CO., LTD. / 2025-07-07
- FDA Project Optimus-Impact and Response Strategy EFFICIENT PHARMA MANAGEMENT CORP. / 2025-07-07
- GoldenBiotech Seminar:Advancing First-Line Therapy for Metastatic Pancreatic Cancer: Global Phase 3 GOLDEN BIOTECHNOLOGY CORP. / 2025-07-07
- Igus and JYTC walk together for better options. (German beer limited served daily) JYTC CO., LTD. / 2025-07-05
- Seminar JAPAN FOOD RESEARCH LABORATORIES(JFRL) / 2025-07-04
- Next Generations Therapy Manufacturing LEVITRONIX GMBH TAIWAN BRANCH / 2025-07-03
- The Fastest and Safest Depth Filtration LEVITRONIX GMBH TAIWAN BRANCH / 2025-07-03
- Highest Cell Viability in Perfusion LEVITRONIX GMBH TAIWAN BRANCH / 2025-07-03
- IOT無線連續監測系統 - 廠房、倉儲、實驗室 溫、濕度測繪 XIN TOP CORPORATION / 2025-07-03
- All-in-One Solution! EliteGro™ Adv.-GI Viral Inactivation Formula Delivers Both Viral Safety and Cel NK BIOTECHNOLOGY / 2025-07-03
- Anti-Aging and Healthy Lifespan Benefits: The Role of Tocotrienols and Squalene (STGaia) PHYTOGAIA SDN BHD / 2025-07-02
- Tocotrienols (TocoGaia) for Healthy Brain and Cognition PHYTOGAIA SDN BHD / 2025-07-02
- The Role of Tocotrienols (TocoGaia) in Liver Health PHYTOGAIA SDN BHD / 2025-07-02
- Minaris Advanced Therapies launches as a global leader in cell therapy MINARIS ADVANCED THERAPIES CO., LTD. / 2025-07-02
- Indiana - America's Life Sciences Powerhouse INDIANA ECONOMIC DEVELOPMENT CORPORATION, TAIWAN OFFICE / 2025-07-01
- Japanese Experts Ryuji Kato and Masahiro Kino-oka to Present on QbD, PAT, and Automation in Cell Man PURPLE WIN INTERATIONAL LIMITED. / 2025-06-27
